Serotonin syndrome
Serotonin syndrome (serotonin toxicity) is a potentially life-threatening reaction caused by too much serotonin activity in the brain, usually from combining two or more serotonergic drugs. It's the main reason certain drug combinations are dangerous — especially MDMA, stimulants, or psychedelics mixed with antidepressants (SSRIs, SNRIs) or MAOIs. It ranges from mild to rapidly fatal, and it's a medical emergency.
Overview
Serotonin syndrome, more precisely called serotonin toxicity, is a drug-induced condition caused by excessive serotonin activity in the nervous system. It classically presents as a triad: neuromuscular abnormalities (tremor, muscle rigidity, overactive reflexes, and clonus — rhythmic involuntary muscle contractions, the most telling sign), autonomic hyperactivity (fever, sweating, rapid heart rate, high blood pressure), and altered mental state (agitation, confusion, restlessness). It exists on a spectrum from mild and easily missed to a rapidly progressing, fatal emergency. There is no lab test that confirms it — diagnosis is clinical. Onset is usually fast, often within hours of the triggering dose or combination.
Source: peer-reviewed literature (NIH/PMC); Cleveland Clinic Journal of Medicine; Wikipedia (CC-BY-SA)
Risks & harms
Serotonin syndrome is the specific danger behind many 'do not combine' warnings in harm reduction. It most often occurs when two or more serotonin-raising substances are taken together, especially if they raise serotonin by different mechanisms — the highest-risk combination is a monoamine oxidase inhibitor (MAOI) with an SSRI, SNRI, or another serotonergic drug. Substances that commonly contribute include MDMA and MDA, other stimulants, tramadol, meperidine (pethidine), dextromethorphan (DXM), St. John's Wort, triptans, and antidepressants (SSRIs, SNRIs, MAOIs, tricyclics). A critical and under-recognized case is ayahuasca, which contains MAOIs — combining it with other serotonergic drugs (SSRIs, MDMA, other stimulants) can be acutely dangerous. It can also occur from a single serotonergic drug taken in overdose. Because some drugs (like fluoxetine, and irreversible MAOIs) stay active for weeks, a dangerous interaction can occur even weeks after stopping one drug. Warning signs to act on: agitation or confusion, heavy sweating and fever, shivering or muscle twitching/jerking, a racing heart, and muscle rigidity. Severe cases cause dangerously high body temperature, seizures, and organ failure. This is a medical emergency — if someone shows these signs after taking serotonergic drugs, call 911 immediately; Poison Control (1-800-222-1222) can advise. Do not wait for the full triad to appear. This page has not yet been medically reviewed.
Source: peer-reviewed literature (NIH/PMC); Cleveland Clinic Journal of Medicine; SAMHSA
Images
Visual references coming soon.
Forensic dossier
Draft · every field is source-cited or marked “Unknown — pending review”Identity
- PubChem CID
- N/A — no single PubChem compound (mixture/class/plant/concept)
- IUPAC name
- N/A — no single PubChem compound (mixture/class/plant/concept)
- Molecular formula
- N/A — no single PubChem compound (mixture/class/plant/concept)
- SMILES
- N/A — no single PubChem compound (mixture/class/plant/concept)
- InChIKey
- N/A — no single PubChem compound (mixture/class/plant/concept)
- Synonyms / aliases
- serotonin toxicity
Composition
- Composition
- Unknown — pending review (no single compound; needs an epidemiology / composition source)
Physical / pill characteristics
- Dosage form
- Unknown — pending review (no Rx/OTC label; illicit — pill visuals = FIRST-PARTY submissions only, never generated or scraped)
- Route
- Unknown — pending review
- Shape
- Unknown — pending review
- Color
- Unknown — pending review
- Imprint
- Unknown — pending review
- Score
- Unknown — pending review
Scheduling & legal status
- US schedule
- Unknown — pending review
- International
- See EMCDDA/EUDA + WHO — synthesize per jurisdictionEMCDDA / EUDA ↗ · retrieved 2026-06-18
Effects
- Effects
- Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus ↗ · retrieved 2026-06-18
Risks
- Risks
- Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus ↗ · retrieved 2026-06-18
Interactions
- Interactions
- Unknown — pending review
